AngioDynamics Exceeds Q1 Revenue and EPS Estimates
AngioDynamics reported first-quarter results that exceeded both revenue and earnings expectations, despite a non-GAAP loss per share of -$0.04 compared to the estimated $-0.11. The company's total revenue reached $80.92 million, up from the previous year by 6.9%. Med Device net sales rose slightly by 1.4% to $41.0 million in Q1. The firm reaffirmed its full-year FY26 outlook following a strong performance in the quarter. The results highlight resilience and growth potential within AngioDynamics' core business segments, particularly as it continues navigating market challenges.
Tickers: $ANGO